Xspray Pharma Future Growth
Future criteria checks 2/6
Xspray Pharma is forecast to grow revenue at 68.1% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Biotechs earnings growth | 27.2% |
Revenue growth rate | 68.1% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 29 May 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,605 | N/A | N/A | N/A | 1 |
12/31/2025 | 789 | N/A | 90 | 184 | 1 |
12/31/2024 | 713 | 596 | -382 | -297 | 2 |
3/31/2024 | N/A | -213 | -257 | -213 | N/A |
12/31/2023 | N/A | -180 | -256 | -203 | N/A |
9/30/2023 | N/A | -180 | -268 | -206 | N/A |
6/30/2023 | N/A | -170 | -242 | -160 | N/A |
3/31/2023 | N/A | -148 | -223 | -128 | N/A |
12/31/2022 | N/A | -132 | -238 | -110 | N/A |
9/30/2022 | N/A | -128 | -216 | -85 | N/A |
6/30/2022 | N/A | -114 | -198 | -79 | N/A |
3/31/2022 | N/A | -102 | -185 | -67 | N/A |
12/31/2021 | N/A | -97 | -148 | -52 | N/A |
9/30/2021 | N/A | -60 | -146 | -53 | N/A |
6/30/2021 | N/A | -57 | -145 | -49 | N/A |
3/31/2021 | N/A | -56 | -141 | -46 | N/A |
12/31/2020 | N/A | -52 | -141 | -48 | N/A |
9/30/2020 | N/A | -56 | -141 | -48 | N/A |
6/30/2020 | N/A | -55 | -140 | -44 | N/A |
3/31/2020 | N/A | -49 | -135 | -35 | N/A |
12/31/2019 | N/A | -46 | -126 | -34 | N/A |
9/30/2019 | -22 | -41 | -115 | -29 | N/A |
6/30/2019 | -14 | -34 | -97 | -24 | N/A |
3/31/2019 | -6 | -30 | -91 | -27 | N/A |
12/31/2018 | 0 | -23 | -65 | -18 | N/A |
9/30/2018 | 31 | -17 | -62 | -25 | N/A |
6/30/2018 | 28 | -16 | -45 | -12 | N/A |
3/31/2018 | 29 | -8 | -38 | -7 | N/A |
12/31/2017 | 0 | -14 | N/A | -12 | N/A |
9/30/2017 | 35 | 1 | N/A | 12 | N/A |
6/30/2017 | 30 | -3 | N/A | -2 | N/A |
3/31/2017 | 21 | -7 | N/A | -6 | N/A |
12/31/2016 | 21 | -4 | N/A | -2 | N/A |
12/31/2015 | 5 | -12 | N/A | -13 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if XSPRAS's forecast earnings growth is above the savings rate (1.8%).
Earnings vs Market: Insufficient data to determine if XSPRAS's earnings are forecast to grow faster than the UK market
High Growth Earnings: Insufficient data to determine if XSPRAS's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: XSPRAS's revenue (68.1% per year) is forecast to grow faster than the UK market (3.5% per year).
High Growth Revenue: XSPRAS's revenue (68.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if XSPRAS's Return on Equity is forecast to be high in 3 years time